medlr news

Lupin Digital Health Introduces Home-Based Care Guide for Cardiac Recovery

Lupin Digital Health, in collaboration with the American College of Cardiology, introduces a Home-Based Care Guide to support heart procedure recovery, reduce complications, and enhance post-procedure care for patients.

medlr news

Livlong 365 Integrates with ABHA to Enhance Digital Healthcare Access

Livlong 365 now integrates with Ayushman Bharat Health Account (ABHA), enabling users to manage their health records digitally across hospitals, clinics, and diagnostic centers, ensuring seamless healthcare access and efficiency.

medlr news

Clove Dental Marks 14th Anniversary with 600th Clinic in Gurugram

Clove Dental celebrates its 14th anniversary with the launch of its 600th clinic in Gurugram, reinforcing its commitment to accessible, tech-driven dental care.

medlr news

NHAI and Amrita Hospital Join Forces to Strengthen Highway Emergency Response

NHAI partners with Amrita Hospital to train ambulance personnel and police teams, strengthening highway emergency response and trauma care.

medlr news

Zeno Health Introduces 50-Minute Medicine Delivery in Mumbai

Zeno Health introduces a 50-minute medicine delivery service in Mumbai, leveraging its tech-driven logistics and retail pharmacy network for fast, reliable access to prescription medicines.

medlr news

Karnataka Highlights Investment Potential in Dermatology and Cosmetic Treatment at KWIN City

Karnataka government highlights investment potential in dermatology and cosmetic treatments, with KWIN City set to become a key healthcare hub.

medlr news

Medtronic’s Evolut Trial Could Reshape the US TAVR Market

Medtronic’s Evolut trial shows promising results, outperforming SAPIEN in key areas. If trends continue, it could shift the US TAVR market, challenging the current market leader.

medlr news

Eli Lilly Introduces Mounjaro in India for Obesity and Type 2 Diabetes

Eli Lilly introduces Mounjaro (tirzepatide) in India, a dual GIP and GLP-1 receptor agonist designed for chronic weight management and type 2 diabetes.

medlr news

BorderPlus and NSDC Collaborate to Empower Indian Healthcare Workers for Global Careers

BorderPlus partners with NSDC to equip Indian healthcare workers with German language training, opening career opportunities in Germany and the DACH region.

medlr news

TERN Group Expands Indo-German Healthcare Workforce Mobility with AI-Driven Ethical Recruitment

TERN Group’s AI-powered Talent Tour connects Indian nurses with German hospitals, fostering ethical migration and workforce development.

medlr news

AiMeD Advocates Balanced Tariff Policies to Strengthen India’s Healthcare Security

AiMeD calls for a reassessment of India's medical device tariffs and regulatory barriers to strengthen domestic manufacturing and healthcare security.

medlr news

Cellogen Therapeutics Secures Patent for India’s First Bi-Specific CAR T Cell Therapy

Cellogen Therapeutics achieves a breakthrough with India’s first Bi-Specific CAR T cell therapy, offering a cutting-edge solution for blood cancers.

medlr news

Aerogen Expands to India with New Headquarters to Advance Respiratory Care

Aerogen establishes its India headquarters in Delhi, aiming to enhance respiratory care with advanced aerosol drug delivery technology. This expansion supports India’s growing healthcare needs, focusing on COPD treatment and strengthening global medtech collaboration.

medlr news

Supriya Lifescience Expands Solar Capacity with New 5 MWp Facility

Supriya Lifescience strengthens its sustainability efforts with a new 5 MWp solar facility in Maharashtra, increasing its total solar capacity to 9.85 MWp. This initiative supports India’s renewable energy goals while enhancing energy efficiency in pharmaceutical manufacturing.

medlr news

Infinx Acquires Glidian to Enhance Prior Authorization and Patient Access Solutions

Infinx has acquired Glidian to enhance AI-driven prior authorization and patient access solutions, expanding its reach in the laboratory market.

medlr news

Peptris Technologies Licenses India’s First AI-Discovered Drug to Revio Therapeutics

Peptris Technologies partners with Revio Therapeutics to advance PEPR124 (RT001), India’s first AI-discovered drug candidate for Duchenne muscular dystrophy (DMD). The agreement accelerates AI-driven drug discovery and expands global biotech reach.

medlr news

India’s First Resuscitation Academy Opens in Hyderabad with Leadership Workshop

Hyderabad hosts India’s first Resuscitation Academy, aiming to improve cardiac arrest survival rates through expert-led training and global collaboration.

medlr news

Shilpa Medicare Introduces Hybrid CDMO Model at DCAT 2025

Shilpa Medicare introduces its hybrid CDMO at DCAT 2025, offering a dual-service model with tailored development partnerships and exclusive B2B licensing, enabling pharma companies to accelerate market entry while leveraging Shilpa’s expertise in oncology, biologics, and peptide manufacturing.

medlr news

India’s First Intestinal Rehabilitation Centre Opens in Mumbai

Rela Hospital introduces India’s first Intestinal Rehabilitation Centre, offering specialized medical, surgical, and nutritional care for children with intestinal failure and complex gastrointestinal conditions.

medlr news

Zydus Acquires 86% Stake in Amplitude Surgical: A Strategic Move in MedTech

Zydus Lifesciences is set to acquire 86% of Amplitude Surgical, strengthening its presence in MedTech with innovative orthopedic solutions.

healthcare news

Glenmark Launches Glempa Range to Combat Diabetes and Heart Disease

Glenmark introduces Glempa, a new range of Empagliflozin-based medications to manage type 2 diabetes and cardiovascular risks, offering flexible treatment options for better health outcomes.

Medlr

Alkem Labs Cuts Diabetes Drug Cost by 80% with Empanorm Launch

Alkem Labs introduces Empanorm, an affordable generic empagliflozin, reducing costs by 80% and enhancing diabetes care with patient-friendly features.

Medlr

Aster DM Healthcare Promoters Reduce Share Pledge to 41% After Debt Refinancing

Aster DM Healthcare promoters have reduced their pledged shares from 99% to 41% after refinancing with JP Morgan, HSBC, and Barclays, improving financial stability and loan terms.

Medlr

AstraZeneca Pharma India Secures CDSCO Approval for Durvalumab in LS-SCLC Treatment

AstraZeneca Pharma India gains CDSCO approval for durvalumab in LS-SCLC, marking a breakthrough in early-stage lung cancer treatment post-CRT.